Paper36001024
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.
Anurag M and 38 others. Cancer Discov, 2022. Cited by 114 papers, by iCite.
Cite this record
ConductScience Library. Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. Papers, record 36001024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36001024
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Triple Negative Breast Neoplasms | Major topic |
| Proteogenomics | Major topic |
| Humans | |
| Carboplatin | |
| Proteomics | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Neoadjuvant Therapy | |
| X-ray Repair Cross Complementing Protein 1 |
Source PubMed
Grants17
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U54 CA224076 | NCI NIH HHS | United States | U54CA224076 | PubMed and NIH | NIH RePORTER |
| R03 OD032626 | NIH HHS | United States | R03OD032626 | PubMed | NIH RePORTER |
| U24 CA271075 | NCI NIH HHS | United States | U24CA271075 | PubMed and NIH | NIH RePORTER |
| U24 CA270823 | NCI NIH HHS | United States | U24CA270823 | PubMed and NIH | NIH RePORTER |
| P30 CA125123 | NCI NIH HHS | United States | P30CA125123 | PubMed | NIH RePORTER |
| S10 OD028671 | NIH HHS | United States | S10OD028671 | PubMed | NIH RePORTER |
| U24 CA210979 | NCI NIH HHS | United States | U24CA210979 | PubMed | NIH RePORTER |
| U01 CA214125 | NCI NIH HHS | United States | U01CA214125 | PubMed and NIH | NIH RePORTER |
| T32 CA203690 | NCI NIH HHS | United States | T32CA203690 | PubMed and NIH | NIH RePORTER |
| P50 CA186784 | NCI NIH HHS | United States | P50CA186784 | PubMed and NIH | NIH RePORTER |
| U24 CA210954 | NCI NIH HHS | United States | U24CA210954 | PubMed and NIH | NIH RePORTER |
| U24 CA160034 | NCI NIH HHS | United States | U24CA160034 | PubMed and NIH | NIH RePORTER |
| U24 CA210986 | NCI NIH HHS | United States | U24CA210986 | PubMed and NIH | NIH RePORTER |
| K12 CA167540 | NCI NIH HHS | United States | K12CA167540 | PubMed | NIH RePORTER |
| U24 CA226110 | NCI NIH HHS | United States | U24CA226110 | PubMed and NIH | NIH RePORTER |
| U54 CA224083 | NCI NIH HHS | United States | U54CA224083 | PubMed and NIH | NIH RePORTER |
| K22 CA241113 | NCI NIH HHS | United States | K22CA241113 | PubMed and NIH | NIH RePORTER |
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27641504 | A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds. | Cell | 2016 | https://conductscience.org/library/papers/27641504 | PubMed |
| 2 | 26131740 | DNA Ligases I and III Support Nucleotide Excision Repair in DT40 Cells with Similar Efficiency. | Photochem Photobiol | 2015 | https://conductscience.org/library/papers/26131740 | PubMed |
| 3 | 10559260 | Long patch base excision repair with purified human proteins. DNA ligase I as patch size mediator for DNA polymerases delta and epsilon. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10559260 | PubMed |
| 4 | 25360585 | BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children. | Mod Pathol | 2015 | https://conductscience.org/library/papers/25360585 | PubMed |
| 5 | 17671126 | Triple-negative breast cancer: clinical features and patterns of recurrence. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17671126 | PubMed |
| 6 | 19223467 | DNA ligase I deficiency leads to replication-dependent DNA damage and impacts cell morphology without blocking cell cycle progression. | Mol Cell Biol | 2009 | https://conductscience.org/library/papers/19223467 | PubMed |
| 7 | 17785706 | Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17785706 | PubMed |
| 8 | 29344893 | Profiling Tumor Infiltrating Immune Cells with CIBERSORT. | Methods Mol Biol | 2018 | https://conductscience.org/library/papers/29344893 | PubMed |
| 9 | 18971340 | High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18971340 | PubMed |
| 10 | 25907283 | Microtubule affinity-regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non-small cell lung cancer. | Int J Cancer | 2015 | https://conductscience.org/library/papers/25907283 | PubMed |
| 11 | 33041185 | Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients. | Eur J Cancer | 2022 | https://conductscience.org/library/papers/33041185 | PubMed |
| 12 | 21558518 | A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. | JAMA | 2011 | https://conductscience.org/library/papers/21558518 | PubMed |
| 13 | 1581963 | Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents. | Cell | 1992 | https://conductscience.org/library/papers/1581963 | PubMed |
| 14 | 32509178 | MARK2 enhances cisplatin resistance via PI3K/AKT/NF-κB signaling pathway in osteosarcoma cells. | Am J Transl Res | 2020 | https://conductscience.org/library/papers/32509178 | PubMed |
| 15 | 27836980 | Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction. | Mol Cell Proteomics | 2017 | https://conductscience.org/library/papers/27836980 | PubMed |
| 16 | 28045625 | Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance). | J Clin Oncol | 2017 | https://conductscience.org/library/papers/28045625 | PubMed |
| 17 | 30563849 | A Curated Resource for Phosphosite-specific Signature Analysis. | Mol Cell Proteomics | 2019 | https://conductscience.org/library/papers/30563849 | PubMed |
| 18 | 12124343 | Replication failure, genome instability, and increased cancer susceptibility in mice with a point mutation in the DNA ligase I gene. | Cancer Res | 2002 | https://conductscience.org/library/papers/12124343 | PubMed |
| 19 | 782919 | DNA ligases of eukaryotes. | FEBS Lett | 1976 | https://conductscience.org/library/papers/782919 | PubMed |
| 20 | 21527027 | GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. | Genome Biol | 2011 | https://conductscience.org/library/papers/21527027 | PubMed |
Cited by81
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42972023 | Early temporal transcriptional and cytokine responses distinguish chemotherapy sensitivity in patient-derived xenograft models of triple-negative breast cancer. | Oncogene | 2026 | https://conductscience.org/library/papers/42972023 | PubMed |
| 42573022 | Proteomic Biomarker Discovery in Breast Cancer: Advances, Challenges, and Translational Prospects. | J Biochem Mol Toxicol | 2026 | https://conductscience.org/library/papers/42573022 | PubMed |
| 42559234 | CTPS1 is an unexplored vulnerability in breast and ovarian cancer. | Theranostics | 2026 | https://conductscience.org/library/papers/42559234 | PubMed |
| 42510676 | Immune-Metabolic Profiling Reveals Functional Heterogeneity Within Colorectal Cancer Consensus Molecular Subtypes. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42510676 | PubMed |
| 42456172 | LIG1 Loss in TP53-mutant Triple Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP-ATR Inhibitor Combinations. | Mol Cancer Ther | 2026 | https://conductscience.org/library/papers/42456172 | PubMed |
| 42305586 | 3D EM uncovers mitochondrial network remodeling in residual triple negative breast cancer after conventional chemotherapy treatments. | iScience | 2026 | https://conductscience.org/library/papers/42305586 | PubMed |
| 42237373 | Proteomics in bone malignancies: from bulk profiling to single-cell and ultra-low-input technologies. | J Transl Med | 2026 | https://conductscience.org/library/papers/42237373 | PubMed |
| 42219424 | Discovery of a novel dual-target modulator of ULK1 and ERK1/2 that suppresses triple-negative breast cancer progression and metastasis via the Exo70/Cav-1/MMPs axis. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42219424 | PubMed |
| 42140958 | Identification and functional validation of EPS15L1 as a key driver of triple-negative breast cancer. | NPJ Breast Cancer | 2026 | https://conductscience.org/library/papers/42140958 | PubMed |
| 42074251 | Identification and Integration of LRG1-Induced Differentially Expressed Gene (DEG) Hub Profiles in Breast Cancer Cells. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074251 | PubMed |
| 42056559 | Crosstalk between integrin signaling and NAD⁺ biosynthetic pathways promotes glycolysis, proliferation, survival, and tumor growth in triple-negative breast cancer. | Oncogene | 2026 | https://conductscience.org/library/papers/42056559 | PubMed |
| 42034977 | MultiOmicsXplorer, a tool to browse, access and analyse multi-omics data. | BMC Bioinformatics | 2026 | https://conductscience.org/library/papers/42034977 | PubMed |
| 41977343 | Contribution of Mesenchymal-like and Epithelial Cellular Subsets to Chemotherapy Resistance in Triple-Negative Breast Cancer. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977343 | PubMed |
| 41975515 | Proteogenomic decoding of chemotherapy resistance in patients with triple-negative breast cancer. | Genome Biol | 2026 | https://conductscience.org/library/papers/41975515 | PubMed |
| 41810343 | Cancer stem cell markers, chemotherapy response, and survival in triple-negative breast cancer. | World J Clin Oncol | 2026 | https://conductscience.org/library/papers/41810343 | PubMed |
| 41604018 | Deciphering RNA and protein expression discordance identifies TOP2A as a prognostic biomarker and potential therapeutic target in lung adenocarcinoma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41604018 | PubMed |
| 41540000 | Bisphosphate nucleotidase 1 promotes progression and docetaxel resistance in triple-negative breast cancer via STUB1-mediated destabilization of LIMA1. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41540000 | PubMed |
| 41465346 | Comparative Tumor Microenvironment Analysis for HCC and PDAC Using KMplotter. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465346 | PubMed |
| 41310667 | Targeting the MAGED2-TRIM28-FLNC axis overcomes chemoresistance in TNBC via EMT suppression. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/41310667 | PubMed |
| 41279138 | Contribution of Mesenchymal-like and Epithelial Cellular Subsets to Chemotherapy Resistance in Triple-Negative Breast Cancer. | bioRxiv | 2025 | https://conductscience.org/library/papers/41279138 | PubMed |
Genes55
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36001024
GET https://conductscience.org/api/papers/v1/36001024/authors?page=2